Marc Shamier from Erasmus MC outlined how the #POSDiseaseX study is crucial task tackling unknown emerging #infectiousdiseases and their impact on high-risk immunocompromised patients. European Commission Horizon Europe 🇪🇺 Horizon 2020 News #Horizon2020 #ECRAIDBase

Monkeypoxvaccinatie is ook van start gegaan bij GGD Rotterdam. Er is een team van het ErasmusMC aanwezig om onderzoek te doen naar de afweer en bescherming na vaccinatie. Deze kennis zal ons helpen om het monkeypox virus te bestrijden.

We monitored a professional soccer team during the first year of the pandemic restrictions. Competition continued under strict physical distancing and frequent testing. Small number of cases and clusters sciencedirect.com/science/articl…

Representatives of the ECRAID-Base POS studies visited our HQ in Utrecht for an operational meeting. Productive discussions were held over two days to assess progress and tackle challenges. Ana C Hernandez Marc Shamier Marc Bonten @rachelvdpols

Today I spoke with RTL nieuws about the Qdenga vaccine that helps protect against Dengue disease. This vaccine is now available in the Netherlands.

Off topic - maar ook microbiologie: vanavond aandacht voor dengue vaccin bij RTL4 met Marc Shamier arts-microbioloog i.o. en PhD student bij Viroscience (wel weer plaatje dat laat zien hoe moeilijk infectiepreventie in 🏥kan zijn in bijv 🇮🇳) rtlnieuws.nl/nieuws/nederla…

Just spoke to NBC about the potential of new mpox outbreaks in Summer 2023. Continued awareness among those at risk for infection as well as health care professionals is crucial. nbcnews.com/health/mens-he… via @nbcnews

There is no better way to ensure the future of clinical research than engaging those who will conduct it. Read our #ECCMID2023 wrap-up story and what our Young Investigators had to say about their experience. tinyurl.com/crh87pt9 #clinicalresearch #infectiousdiseases

⚠️ BREAKING: Two poultry workers test positive for H5N1 bird flu in the UK 🇬🇧

I am honored to have my profile featured in The Lancet Infectious Diseases! Many thanks to the editorial team of TLID and Tony Kirby for this incredible opportunity, as well as my inspiring colleagues and supervisors who have supported me along the way! thelancet.com/journals/lanin…

Excited to share our recent contribution in The Lancet Infectious Diseases! In our commentary, we address knowledge gaps regarding mpox immunity and the need for future studies. Corine GeurtsvanKessel Luca Zaeck 🦠🔬 Rory de Vries Marion Koopmans, publications: https://pure.eur.nl The Lancet Infectious Diseases thelancet.com/journals/lanin…

📣 POS-Disease X began enrolling patients! This ECRAID-Base study uses novel techniques to find & identify new viruses posing a threat to public health 🦠 Congratulations to the the study team led by Marion Koopmans, publications: https://pure.eur.nl at Erasmus MC 👏🏽 📸 Corine GeurtsvanKessel, Janko van Beek & Marc Shamier

Come meet the POS-Disease X study team at #ESCMIDGlobal2024! Janko van Beek and Marc Shamier will be at the Ecraid booth (E81) ready to discuss collaborations: 📅 Today (Sun) 14:00-15:00 📅 Tomorrow (Mon) 11:00-12:00 #ECCMID2024 ESCMID Erasmus MC Intl Erasmus MC Marion Koopmans, publications: https://pure.eur.nl